Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.

Saved in:
Bibliographic Details
Title: Atogepant reduces triptan use: a pharmacoeconomic analysis in migraine prevention.
Authors: Guerzoni S; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology, Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, 41124, Modena, Italy., Pellesi L; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, 5230, Denmark. lpellesi@health.sdu.dk., Giannessi L; CliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, Bologna, Italy., Lo Castro F; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology, Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, 41124, Modena, Italy., Olivieri MC; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology, Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, 41124, Modena, Italy., Degli Esposti L; CliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, Bologna, Italy., Gandolfi F; Distribuzione Diretta AUSL Modena, Dipartimento Farmaceutico Interaziendale, Modena, Italy.
Source: The journal of headache and pain [J Headache Pain] 2026 Jun 20; Vol. 27 (1). Date of Electronic Publication: 2026 Jun 20.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377 (Electronic) Linking ISSN: 11292369 NLM ISO Abbreviation: J Headache Pain Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first